Moreover, innovative use of IHC, such as CD117, in conjunction with specific enhancement features on CT, can be useful in differentiating benign oncocytomas and indolent hybrid tumours from malignant chromophope RCC.26 This evidence concerns the gene KIT and neoplasm.